---
title: "Syros Pharma (SYRS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SYRS.US/norm.md"
symbol: "SYRS.US"
name: "Syros Pharma"
parent: "https://longbridge.com/en/quote/SYRS.US.md"
datetime: "2026-03-14T01:54:18.316Z"
locales:
  - [en](https://longbridge.com/en/quote/SYRS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SYRS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SYRS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SYRS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SYRS.US/norm.md)


# Syros Pharma (SYRS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1626 | -0.5940 | -0.0951 | -2.18 | -1.43 |
| ROE | 292.81% | -2143.78% | -93.52% | -972.49% | -293.17% |
| Revenue | - | - | - | 386000.00 | 3.76M |
| Net income | -6.40M | -23.33M | -3.71M | -64.38M | -40.14M |
| Operating income | -26.18M | -27.42M | -30.92M | -27.00M | -32.28M |
| Gross margin | - | - | - | -5470.73% | -651.73% |
| Net margin | - | - | - | -16679.79% | -1067.07% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 85.00M | 106.72M | 134.73M | 168.17M | 147.79M |
| Leverage | -7.64 | -16.80 | 8.95 | 10.09 | 4.07 |
| BVPS | -0.4145 | -0.2369 | 0.5633 | 0.6300 | 1.75 |
| Turnover | 0.0033 | 0.0288 | 0.0411 | 0.0482 | 0.0407 |
| Cash & STI | 58.27M | 78.96M | 108.30M | 139.53M | 112.22M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 17.58M | 18.22M | 18.86M | 19.48M | 20.08M |
| Net debt | 1.95M | -18.30M | -46.63M | -77.45M | -49.76M |

## Cash Flow Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -20.69M | -29.67M | -31.10M | -18.56M | -31.86M |
| Investing CF | 0.0000 | 25.07M | -24.64M | 1.52M | 28.64M |
| Financing CF | 0.0000 | 41000.00 | -265000.00 | 43.38M | -5000.00 |
| Free CF | -10.33M | -18.26M | -19.80M | -6.80M | -19.68M |
| OCF coverage | - | - | - | -45273.17% | -637160.00% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | -38000.00 | 0.0000 |